HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and side-effects of decitabine in treatment of atypical chronic myeloid leukemia.

AuthorsXiuzhen Tong, Juan Li, Zhenhai Zhou, Dong Zheng, Junru Liu, Chang Su
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 56 Issue 6 Pg. 1911-3 (Jun 2015) ISSN: 1029-2403 [Electronic] United States
PMID25426665 (Publication Type: Case Reports, Letter)
Chemical References
  • Antimetabolites, Antineoplastic
  • Decitabine
  • Azacitidine
Topics
  • Adult
  • Anemia (chemically induced)
  • Antimetabolites, Antineoplastic (adverse effects, therapeutic use)
  • Azacitidine (adverse effects, analogs & derivatives, therapeutic use)
  • Chromosome Aberrations
  • Decitabine
  • Fatal Outcome
  • Female
  • Humans
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (drug therapy, genetics, pathology)
  • Male
  • Middle Aged
  • Remission Induction
  • Thrombocytopenia (chemically induced)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: